<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Volgograd State Medical University</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Volgograd State Medical University</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Волгоградского государственного медицинского университета</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-9480</issn><issn publication-format="electronic">1994-9499</issn><publisher><publisher-name xml:lang="en">Volgograd State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">140235</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">IMPORTANCE OF ANTIBODIES TO ERYTHROCYTAL SUPEROXIDE DISMUTASE IN CHANGE OF ITS ACTIVITY IN SYSTEMIC SCLEROSIS</article-title><trans-title-group xml:lang="ru"><trans-title>ЗНАЧЕНИЕ АНТИТЕЛ К ЭРИТРОЦИТАРНОЙ СУПЕРОКСИДДИСМУТАЗЕ В ИЗМЕНЕНИИ ЕЕ АКТИВНОСТИ ПРИ СИСТЕМНОЙ СКЛЕРОДЕРМИИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shilova</surname><given-names>Lyudmila Nikolaevna</given-names></name><name xml:lang="ru"><surname>Шилова</surname><given-names>Людмила Николаевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра госпитальной терапииассистент; ВолгГМУ, Научно-исследовательский институт клинической и экспериментальной ревматологии</p></bio><email>ludshilova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Emel'yanov</surname><given-names>N N</given-names></name><name xml:lang="ru"><surname>Емельянов</surname><given-names>Н Н</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра госпитальной терапии; ВолгГМУ, Научно-исследовательский институт клинической и экспериментальной ревматологии</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Shilova</surname><given-names>L N</given-names></name><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name><surname>Emeljanov</surname><given-names>N N</given-names></name><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ВолгГМУ, Научно-исследовательский институт клинической и экспериментальной ревматологии</institution></aff></aff-alternatives><aff id="aff2"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="2011-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2011</year></pub-date><volume>8</volume><issue>3</issue><issue-title xml:lang="en">NO3 (2011)</issue-title><issue-title xml:lang="ru">№3 (2011)</issue-title><fpage>39</fpage><lpage>41</lpage><history><date date-type="received" iso-8601-date="2023-01-27"><day>27</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2011, Shilova L.N., Emel'yanov N.N., Shilova L.N., Emeljanov N.N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2011, Шилова Л.Н., Емельянов Н.Н., Shilova L.N., Emeljanov N.N.</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="en">Shilova L.N., Emel'yanov N.N., Shilova L.N., Emeljanov N.N.</copyright-holder><copyright-holder xml:lang="ru">Шилова Л.Н., Емельянов Н.Н., Shilova L.N., Emeljanov N.N.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/1994-9480/article/view/140235">https://journals.eco-vector.com/1994-9480/article/view/140235</self-uri><abstract xml:lang="en"><p>A technique of immunoenzyme diagnostics of the level of antibodies to Superoxide Dismutase (SOD) on the basis of an immobilized form of magnet sorbent was developed for immune diagnostics of systemic sclerosis (SS) for the first time. Antibodies to SOD were found in sera of SS patients, their concentration correlates with the activity and course of disease. It is shown that the level of antibodies to SOD reliably differs from content of these antibodies in sera of healthy individuals. Detection of antibodies to SOD by means of the proposed method can be used as one of tests for SS diagnostics to determine the extent and course of the disease. The data we obtained demonstrate that antibodies to SOD invoke a decrease of enzymatic activity in vitro. Therefore the antibodies to enzyme may be one of the possible causes of decrease of SOD activity in patients.</p></abstract><trans-abstract xml:lang="ru"><p>Для первичной иммунной диагностики системного склероза была разработана методика иммуноферментного определения уровня антител к супероксиддисмутазе (СОД) с использованием иммобилизированных антигенных форм энзимов. В крови больных с системной склеродермией выявляются антитела к СОД, продукция которых увеличивается с возрастанием активности процесса, наличием более тяжелых форм течения заболевания и сопровождается со снижением активности фермента. Следовательно, одной из причин угнетения антиоксидантной активности СОД, вероятно, могут явиться аутоантитела к энзиму.</p></trans-abstract><kwd-group xml:lang="en"><kwd>rheumatic process</kwd><kwd>systemic sclerosis</kwd><kwd>autoantibodies</kwd><kwd>antioxidant system</kwd><kwd>Superoxide Dismutase</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ревматический процесс</kwd><kwd>системная склеродермия</kwd><kwd>аутоантитела</kwd><kwd>антиоксидантная система</kwd><kwd>супероксиддисмутаза</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Гусева Н. Г. // РМЖ. - 2000. - Т. 8, № 9.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Зборовская И. А. Ревматические болезни и антиоксидантная система. - М.: «Медицина», 2005. - 127 с.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Малахов А. Б., Давтян В. Г., Геппе Н. А., Осминина М. К. // Consilium medicum. - 2006. - Т. 8, № 2.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Artlett C. M. // Front. Biosci. - 2005. - Vol. 10. p 1707-1719.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Ohung C. P., Avalos I., Stein C. M. // Free Radic.Biol. Med. - 2006. - May 15. - Vol. 40(10). - P. 1698-1699.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Denton C. P., Black C. M., Abraham D. J. // Nat. Clin. Pract. Rheumatol. - 2006. - Mar. - Vol. 2(3). - P. 134-144.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Dooley A., Gao. B., Bradley N., et al. // Annals of the New York Academy of Sci. - 2005. - Jun. - Vol. 1051. - P. 455-464.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Johnson S. R., Glaman D. D., Schentag C. T., Lee P. Il J-Rheumatol. - 2006. - Jun. - Vol. 33(6). - P. 1117-1122.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Tikly M., Channa K., Theodorou P., Gulumian M. // Clin. Rheumatol. - 2006. - May. - Vol. 25(3). P. 320-324.</mixed-citation></ref></ref-list></back></article>
